FHIR IG analytics

Resources that use this resource

Resources that this resource uses

Narrative

No narrative content found in resource

Source1

{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.464.1003.199.11.1108",
  "meta": {
    "versionId": "7",
    "lastUpdated": "2024-01-30T18:19:05.000-05:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail": {
        "name": "NCQA PHEMUR Author"
      }
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate": "2025-01-08"
    },
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate": "2021-02-24"
    }
  ],
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.199.11.1108",
  "identifier": [
    {
      "system": "urn:ietf:rfc:3986",
      "value": "urn:oid:2.16.840.1.113883.3.464.1003.199.11.1108"
    }
  ],
  "version": "20210224",
  "name": "InfluenzaVirusLAIVVaccineAdministered",
  "title": "Influenza Virus LAIV Vaccine Administered",
  "status": "active",
  "experimental": false,
  "date": "2021-02-24T01:00:28-05:00",
  "publisher": "NCQA PHEMUR",
  "jurisdiction": [
    {
      "coding": [
        {
          "system": "urn:iso:std:iso:3166",
          "code": "US"
        }
      ]
    }
  ],
  "purpose": "(Clinical Focus: The purpose of this value set is to represent administration of live attenuated influenza vaccine.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent procedures for live attenuated influenza vaccination (quadrivalent and trivalent).),(Exclusion Criteria: Excludes concepts that represent procedures for recombinant or inactivated influenza vaccination.)",
  "compose": {
    "include": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "concept": [
          {
            "code": "90660",
            "display": "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"
          },
          {
            "code": "90672",
            "display": "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"
          }
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:10bfcc94-82a1-42d9-ab0f-deb493b806c4",
    "timestamp": "2025-05-23T22:35:26-04:00",
    "total": 2,
    "contains": [
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "90660",
        "display": "Influenza virus vaccine, trivalent, live (LAIV3), for intranasal use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2025",
        "code": "90672",
        "display": "Influenza virus vaccine, quadrivalent, live (LAIV4), for intranasal use"
      }
    ]
  }
}